Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system.

Cancer medicine - 1 Sept 2020

Lee Petra W C, Bedard Angela C, Samimi Setareh, Beard Vivienne K, Hong Quan, Bedard James E J, Gilks Blake, Schaeffer David F, Wolber Robert, Kwon Janice S, Lim Howard J, Sun Sophie, Schrader Kasmintan A

Abstract excerpt

PURPOSE: Referrals for Lynch syndrome (LS) assessment have traditionally been based on personal and family medical history. The introduction of universal screening practices has allowed for referrals based on immunohistochemistry tests for mismatch repair (MMR) protein expression. This study aims to characterize the effect of universal screening in a publicly funded healthcare system with comparison to patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to British Columbia
Share to Colorectal Neoplasms, Hereditary Nonpolyposis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to DNA Mismatch Repair

Share to DNA Repair Enzymes

Share to Early Detection of Cancer

Share to National Health Programs

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 32700475
DOI: 10.1002/cam4.3279
PMCID: PMC7520344

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system.PMID 32700475Read ↗

A systems approach to enhance Lynch syndrome diagnosis through tumor testingSemantic proximity Read ↗

Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohortSemantic proximity Read ↗

Universal Testing to Identify Lynch Syndrome Among Women With Newly Diagnosed Endometrial Carcinoma.Semantic proximity Read ↗

Population-based molecular screening for Lynch syndrome: implications for personalized medicine.Semantic proximity Read ↗

Population-Level Identification of Patients With Lynch Syndrome for Clinical Care, Quality Improvement, and Research.Semantic proximity Read ↗

Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.Semantic proximity Read ↗

Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.Semantic proximity Read ↗

Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathwaySemantic proximity Read ↗

Impact of population screening for Lynch syndrome insights from the All of Us data.Semantic proximity Read ↗

Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.Semantic proximity Read ↗

A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndromeSemantic proximity Read ↗

Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.